Sponsor study identifier
observational
59
1 country
5
Study Start
September 5, 2022
Actual (reported)Primary Completion
May 7, 2026
Actual (reported)Study Completion
August 4, 2031
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
This is a Post Market Clinical Follow Up Study in Orthopaedics. It will verify the long-term safety and performance of the device in the intended patient population, when indicated for the reconstruction of a ligament in the kneecap - the Medial Patellofemoral Ligament (MPFL). The Medical Devices in this study, 10mm Poly-Tape and 5mm Infinity-Lock Tape, are Class III CE-Marked devices manufactured by Xiros Ltd. Both devices fall under the Poly-Tape family. Poly-Tapes are single-use devices, they are indicated for patients requiring soft tissue approximation and reconstruction of ligaments and tendons. The device can be fixed to the bone using several different methods, including screws. This study is a prospective, multicentre, consecutively recruited non-randomised study. The total length of the study is expected to be 7 years. This includes a recruitment period of approximately 24 months and a 5-year follow-up. A total of 59 subjects will be enrolled into the study with follow up at 6 weeks, 6 months, 1 year, 2 years and 5 years in clinic and by questionnaires. All subjects treated with either the 10mm Poly-Tape or 5mm Infinity-Lock Tape for MPFL reconstruction, will be consecutively recruited into the study.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
August 4, 2031
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
February 8, 2022
Actual (reported)March 3, 2022
Actual (reported)September 5, 2022
Actual (reported)May 7, 2026
Actual (reported)August 4, 2031
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Kujala Score
The primary performance objective is to determine the effect of MPFL reconstruction on symptoms and functional limitations 1 year after surgery, measured using the Kujala .Total score. Total scores range from 0 to 100 with high scores indicating good
1 year
Redislocation/subluxation events
The primary safety objective is to assess redislocation/subluxation events at 1 year after surgery
1 year
Full range of motion (ROM)
5 years
Norwich Patellar Instability (NPI) score
5 years
Patient-reported quality of life (RANDShort form 36)
5 years
Patient-reported activity levels
5 years
Patient satisfaction with Surgery
5 years
Poly-Tape Devices for Medial Patellofemoral Ligament (MPFL) Reconstruction
Poly-Tape Devices, 10mm Poly-Tape or 5mm Infinity-Lock Tape, for Medial Patellofemoral Ligament (MPFL) Reconstruction
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Patients who require MPFL reconstruction.
James Paget University Hospitals NHS Foundation Trust
Great Yarmouth, NR31 6LA, United Kingdom
Tameside and Glossop Integrated Care NHS Foundation Trust
Manchester, OL6 9RW, United Kingdom
University of North Midlands NHS Trust
Stoke-on-Trent, United Kingdom
Hampshire Hospitals NHS Foundation Trust
Winchester, SO22 5DG, United Kingdom
Somerset NHS Foundation Trust
Yeovil, BA21 4AT, United Kingdom
59 participants (actual enrollment reported by the registry).
First Submitted
February 8, 2022
First Posted
March 3, 2022
Study Start
September 5, 2022
Actual (reported)Contact the study team to confirm eligibility.
Primary Completion
May 7, 2026
Actual (reported)Study Completion
August 4, 2031
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Last Updated
May 15, 2026
Record last verified: 2026-05
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: